Works matching IS 00316970 AND DT 2023 AND VI 79 AND IP 2

Results: 15

Why we should not recommend or offer fluvoxamine to COVID-19 patients?

Published in:

2023

By:

Trkulja, Vladimir

Publication type:

Letter to the Editor

Linezolid pharmacokinetics: a systematic review for the best clinical practice.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 195, doi. 10.1007/s00228-022-03446-4

By:

Heidari, Shima;
Khalili, Hossein

Publication type:

Article

Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 311, doi. 10.1007/s00228-022-03445-5

By:

Ponthier, Laure;
Marquet, Pierre;
Moes, Dirk Jan A. R.;
Rostaing, Lionel;
van Hoek, Bart;
Monchaud, Caroline;
Labriffe, Marc;
Woillard, Jean Baptiste

Publication type:

Article

Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 219, doi. 10.1007/s00228-022-03433-9

By:

Bergs, Ingmar;
Just, Katja S.;
Scholl, Catharina;
Dreher, Michael;
Stingl, Julia C.

Publication type:

Article

Cost-utility analysis of a structured medication review compared to usual care in Parkinson's disease.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 289, doi. 10.1007/s00228-022-03438-4

By:

Oonk, N. G. M.;
Dorresteijn, L. D. A.;
van den Berg, A. D.;
van der Palen, J.;
Movig, K. L. L.;
Nijmeijer, H. W.;
van Kesteren, M. E.;
Koffijberg, H.

Publication type:

Article

Premature termination of clinical trials in Spain: reasons, characteristics, and opportunities to improve.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 249, doi. 10.1007/s00228-022-03437-5

By:

Filippi-Arriaga, Francesca;
Boy, Ricardo Javier;
Del Gobbo, Alejandro Díaz;
Gallego, Alexis Rodríguez

Publication type:

Article

Duplicate prescriptions in the emergency department: a retrospective cohort study.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 207, doi. 10.1007/s00228-022-03436-6

By:

Heck, Johannes;
Krichevsky, Benjamin;
Groh, Adrian;
Schulze Westhoff, Martin;
Laser, Hans;
Gerbel, Swetlana;
Strunz, Patrick-Pascal;
Schumacher, Carsten;
Klietz, Martin;
Stichtenoth, Dirk O.;
Höner zu Siederdissen, Christoph;
Krause, Olaf

Publication type:

Article

The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 243, doi. 10.1007/s00228-022-03435-7

By:

Çağlayan, Dilek;
Koçak, Mehmet Zahid;
Geredeli, Çağlayan;
Tatlı, Ali Murat;
Göksu, Sema Sezgin;
Eryılmaz, Melek Karakurt;
Araz, Murat;
Artaç, Mehmet

Publication type:

Article

Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 299, doi. 10.1007/s00228-022-03444-6

By:

El-attar, Aya Ahmed;
Ibrahim, Osama Mohamed;
Alhassanin, Suzan Ahmed;
Essa, Enas Said;
Mostafa, Tarek Mohamed

Publication type:

Article

Patients with bariatric surgery: Urgent need for accurate registration of the contraindication to enable safe pharmacotherapy in hospital and primary care.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 237, doi. 10.1007/s00228-022-03432-w

By:

Lau, Cedric;
Sbaa, Ouarda;
Smeenk, Robert;
van Kesteren, Charlotte

Publication type:

Article

Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 257, doi. 10.1007/s00228-022-03431-x

By:

Jobski, Kathrin;
Bantel, Carsten;
Hoffmann, Falk

Publication type:

Article

Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)–based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 279, doi. 10.1007/s00228-022-03430-y

By:

Sun, Yingchao;
Yue, Lei;
Hu, Weiling

Publication type:

Article

Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 229, doi. 10.1007/s00228-022-03422-y

By:

Adopo, D.;
Daynes, P.;
Benkebil, M.;
Debs, A.;
Jonville-Berra, AP.;
Polard, E.;
Micallef, J.;
Maison, P.

Publication type:

Article

Reliability and feasibility of home-based dried blood spot in therapeutic drug monitoring: a systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 183, doi. 10.1007/s00228-022-03417-9

By:

Xiaoyong, Xu;
Xilin, Ge;
Guangfei, Wang;
Wei, Wu;
Xiaowen, Zhai;
Hong, Xu;
Huimin, Zhang;
Zhiping, Li

Publication type:

Article

Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan—and the effects of vaccine hesitancy and government policy.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 269, doi. 10.1007/s00228-022-03412-0

By:

Inokuma, Yasuko;
Kneller, Robert

Publication type:

Article